These ZEB1/2-CtBP1/2 repressor complexes are important for downregulating the epithelial marker E-cadherin (CDH1) during carcinoma progression [17,18,19] and during developmental processes such as neurulation and pituitary lactotrope differentiation [13,15]. Here, ZEB1 is linked to carcinoma.